Nifty Pharma Today: Index Performance, Stocks, Gainers & Losers

Updated: 28 Aug 2026 • 4:06 pm

Posted by:

Nifty Pharma Today: Index Performance, Stocks, Gainers & Losers

Table of Contents

Nifty Pharma Today: Snapshot and Closing View

Nifty Pharma ended the session at 26,991.85 on 28 August 2026, up 143.10 points or 0.53% from the previous close of 26,848.75. The index opened at 26,906.55, moved to an intraday high of 27,009.95, and touched a low of 26,786.40 during the day. The latest update used for this analysis is 28 August 2026 at 4:00:04 PM IST, so this page reflects the closing trend and the full-day movement visible in the verified data.

The session was mildly bullish rather than explosive. Nifty Pharma stayed in positive territory by the close, but the gain came with mixed underlying stock action. A 0.53% rise in a diversified sector index usually tells investors that gains in several members outweighed sharp falls in a smaller set of stocks. That is exactly what happened here. Breadth stayed healthy, heavyweight names were largely stable to positive, and a few strong gainers such as Glenmark Pharmaceuticals and Divi's Laboratories helped the index finish in the green.

For traders and long-term market trackers searching for Nifty Pharma today, the important takeaway is that the pharma pack showed broad participation. The index did not merely rise because of a single stock; instead, a majority of constituents advanced. At the same time, losses in JB Chemicals & Pharmaceuticals, Biocon, Mankind Pharma, Abbott India, Ipca Laboratories, and Natco Pharma capped the upside. So the closing picture was positive, but not one-sided.

Metric	Value
Current Value	26,991.85
Absolute Change	+143.10
Percentage Change	+0.53%
Open	26,906.55
Previous Close	26,848.75
Day High	27,009.95
Day Low	26,786.40
Market Status	Closed
Last Updated	28 August 2026 at 4:00:04 PM IST
Market Trend	Bullish

Intraday structure also matters. The index closed very near the day’s high of 27,009.95, which suggests that buying interest remained intact into the end of the session. When an index closes near the upper end of its day range, it often signals that bulls retained control even after intermittent profit booking. That does not confirm a breakout on its own, but it does strengthen the interpretation of a constructive day.

Why Nifty Pharma Moved Higher Today

Based on the verified market data available, today’s move in Nifty Pharma can be explained primarily through price action, breadth, and constituent leadership rather than external macro or policy triggers. The index rose because 14 out of 20 constituents advanced, only 6 declined, and some important pharma names posted meaningful gains.

The most visible strength came from Glenmark Pharmaceuticals Ltd., which gained 2.24%, and Divi's Laboratories Ltd., which rose 1.98%. These were not marginal upticks. In a sector index, stocks moving close to 2% on the upside can materially support the benchmark, especially when the broader breadth is positive. Torrent Pharmaceuticals Ltd. also added 1.02%, further strengthening the top layer of the pack.

Another reason the index held up was the relatively stable performance of heavyweight and widely tracked names. Sun Pharmaceutical Industries Ltd. rose 0.35%, Cipla Ltd. gained 0.25%, Dr. Reddy's Laboratories Ltd. edged up 0.08%, and Zydus Lifesciences Ltd. closed 0.15% higher. Even when these gains look modest on a percentage basis, they matter because stability in heavyweight stocks helps prevent the index from giving back gains generated by mid-pack outperformers.

The index also benefited from a broad cluster of medium gains across the sector. Alkem Laboratories Ltd. rose 0.66%, Lupin Ltd. gained 0.62%, Granules India Ltd. advanced 0.52%, Aurobindo Pharma Ltd. added 0.51%, Gland Pharma Ltd. gained 0.50%, and Laurus Labs Ltd. rose 0.47%. This kind of distribution is important because it points to sector-wide participation rather than isolated buying.

At the same time, the rise was moderated by a few sharp losers. JB Chemicals & Pharmaceuticals Ltd. fell 3.87%, making it the worst-performing stock in the index. Biocon Ltd. declined 1.74% and Mankind Pharma Ltd. lost 1.43%. These declines prevented Nifty Pharma from posting a stronger gain despite positive breadth.

So, if you are asking why Nifty Pharma is rising today, the cleanest answer is this: the sector moved up because a clear majority of constituents gained, several top gainers rose by 1% to 2% or more, and heavyweight names were broadly supportive. The rally was balanced rather than euphoric, with enough decliners to keep the move moderate.

Market Breadth: What the Internal Strength Says

Market breadth is one of the most useful tools for understanding whether an index move is healthy. In Nifty Pharma today, breadth was decisively positive. Out of 20 constituents, 14 stocks advanced and 6 declined, while none remained unchanged. That gives an advance-decline ratio of 2.33, with 70% of constituents in the green and 30% in the red.

Breadth Metric	Value
Advancing Stocks	14
Declining Stocks	6
Unchanged Stocks	0
Advance-Decline Ratio	2.33
Stocks in Green	70%
Stocks in Red	30%

This breadth profile suggests that the upmove was internally supported. A rising index with weak breadth can sometimes be misleading because only a few heavyweight stocks may be driving the benchmark. Here, the breadth numbers tell a better story. More than two advancing stocks were present for every declining stock, which means gains were distributed across the sector.

However, breadth should still be read along with intensity. While 14 stocks rose, only a few posted large gains, and one stock fell nearly 4%. That means participation was strong, but conviction was not uniform. Some names saw only modest upside. As a result, the breadth signals a healthy session, but not a runaway momentum day.

For market participants, this is often a constructive setup. Positive breadth combined with a close near the day’s high usually reflects demand across the group. It can also indicate that sector sentiment is firm even if select counters are going through profit booking or stock-specific pressure.

Complete Nifty Pharma Constituent Performance

The table below captures the full constituent-level performance of Nifty Pharma today based on the verified stock list. Trend is classified from today’s price change only: positive closes are marked bullish and negative closes are marked bearish.

Company	CMP	Today's %	Today's Change	52 Week High	52 Week Low	Trend
JB Chemicals & Pharmaceuticals Ltd.	2,408.90	-3.87%	-97.10	-	-	Bearish
Glenmark Pharmaceuticals Ltd.	2,515.00	+2.24%	+55.00	-	-	Bullish
Divi's Laboratories Ltd.	9,239.00	+1.98%	+179.00	-	-	Bullish
Biocon Ltd.	411.10	-1.74%	-7.30	-	-	Bearish
Mankind Pharma Ltd.	2,382.90	-1.43%	-34.60	-	-	Bearish
Torrent Pharmaceuticals Ltd.	5,050.00	+1.02%	+51.00	-	-	Bullish
Abbott India Ltd.	26,175.00	-0.66%	-175.00	-	-	Bearish
Alkem Laboratories Ltd.	5,355.00	+0.66%	+35.00	-	-	Bullish
Lupin Ltd.	2,171.50	+0.62%	+13.40	-	-	Bullish
Granules India Ltd.	836.65	+0.52%	+4.35	-	-	Bullish
Aurobindo Pharma Ltd.	1,645.30	+0.51%	+8.30	-	-	Bullish
Gland Pharma Ltd.	2,888.00	+0.50%	+14.50	-	-	Bullish
Ipca Laboratories Ltd.	1,950.30	-0.48%	-9.50	-	-	Bearish
Laurus Labs Ltd.	1,938.50	+0.47%	+9.10	-	-	Bullish
Natco Pharma Ltd.	853.80	-0.44%	-3.80	-	-	Bearish
Ajanta Pharma Ltd.	3,557.00	+0.38%	+13.40	-	-	Bullish
Sun Pharmaceutical Industries Ltd.	1,920.00	+0.35%	+6.70	-	-	Bullish
Cipla Ltd.	1,423.50	+0.25%	+3.50	-	-	Bullish
Zydus Lifesciences Ltd.	1,191.00	+0.15%	+1.80	-	-	Bullish
Dr. Reddy's Laboratories Ltd.	1,178.00	+0.08%	+1.00	-	-	Bullish

Top performer today was Glenmark Pharmaceuticals Ltd. with a gain of 2.24%, while the worst performer was JB Chemicals & Pharmaceuticals Ltd. with a decline of 3.87%.

Top Gainers in Nifty Pharma Today

The leading gainers show where buying interest was concentrated. Glenmark and Divi's Laboratories were clearly ahead of the rest, while Torrent Pharmaceuticals rounded out the top tier. These names provided momentum and helped offset weakness elsewhere in the sector.

Company	Price Change	% Change	Interpretation
Glenmark Pharmaceuticals Ltd.	+55.00	+2.24%	Strong upside leadership within the sector
Divi's Laboratories Ltd.	+179.00	+1.98%	Major high-priced contributor to index strength
Torrent Pharmaceuticals Ltd.	+51.00	+1.02%	Solid support from a heavyweight pharma name
Alkem Laboratories Ltd.	+35.00	+0.66%	Steady accumulation and positive close
Lupin Ltd.	+13.40	+0.62%	Moderate gain adding to positive breadth

Within today’s setup, Divi's Laboratories Ltd. deserves special attention because it combines a strong percentage gain with a high absolute price move of 179 points. Glenmark Pharmaceuticals Ltd. delivered the biggest percentage jump among all constituents. Torrent Pharmaceuticals Ltd. also contributed meaningfully by crossing the 1% mark.

These gainers matter not just because they were green, but because they came alongside positive breadth. When top gainers rise on a day when most peers are also up, the move looks healthier than a narrow spike in one or two names.

Top Losers in Nifty Pharma Today

Even on a positive day for the index, losers reveal where pressure persisted. The decline in JB Chemicals & Pharmaceuticals was particularly sharp and stood out against the otherwise constructive sector backdrop.

Company	Price Change	% Change	Interpretation
JB Chemicals & Pharmaceuticals Ltd.	-97.10	-3.87%	Deepest cut in the index and biggest drag by percentage
Biocon Ltd.	-7.30	-1.74%	Notable weakness among large tracked pharma names
Mankind Pharma Ltd.	-34.60	-1.43%	Meaningful decline from a key constituent
Abbott India Ltd.	-175.00	-0.66%	High absolute fall, though percentage damage was moderate
Ipca Laboratories Ltd.	-9.50	-0.48%	Minor drag on an otherwise positive day

The loser table shows an important market dynamic: downside was concentrated. Only six stocks ended in the red, but a few of them fell enough to matter. JB Chemicals & Pharmaceuticals Ltd. was the clear outlier with a near-4% drop. Mankind Pharma Ltd. and Biocon Ltd. were the other meaningful weak spots.

For anyone tracking sector rotation within pharma, this matters because leadership and laggards were clearly separated today. The index rose, but not every stock participated equally. That creates a more selective market beneath the surface.

Heavyweight and Most-Tracked Stocks: What They Tell Us

Among the heavyweight and most-tracked stocks in Nifty Pharma, the tone was largely constructive. Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Ltd., Lupin Ltd., and Aurobindo Pharma Ltd. all closed higher. That is important because index resilience becomes more credible when widely followed leaders are not under pressure.

Only a few key names in this group closed lower, most notably Mankind Pharma Ltd. and Abbott India Ltd.. Their weakness limited the overall rise, but did not reverse the positive sector tone.

From a market reading perspective, the combination of broad advances and stability in major tracked stocks usually indicates a balanced up day. It suggests investors were willing to stay exposed to the sector rather than crowding into only defensive corners of the basket.

Technical Reading Based on Available Price Action

This technical view is based on the verified intraday price range and closing behavior available for the index. Nifty Pharma opened at 26,906.55, dipped to 26,786.40, and then climbed to close at 26,991.85, very close to the session high of 27,009.95. That intraday pattern points to recovery after early pressure and a firm finish into the close.

In plain language, the day’s chart structure appears constructive. The index absorbed selling below the open, held the lower end of the day’s range, and then recovered enough to end near the high. That kind of session often reflects demand emerging on dips. It does not by itself confirm a larger trend change, but it does show that buyers had the stronger hand by the end of trade.

The immediate reference points from today’s session are clear. The day low near 26,786.40 acts as a near-term downside reference, while the day high around 27,009.95 acts as the nearest upside hurdle from today’s trade. The closing level just below the high suggests the index is ending the day with positive short-term momentum based on available price action.

Because broader moving-average and oscillator data are not part of the verified input here, the most reliable technical conclusion is simple: Nifty Pharma closed bullish on the day, breadth supported the move, and the finish near the upper end of the range keeps short-term sentiment constructive as long as the market respects today’s lower band.

Historical and Relative Performance View

For today’s session, Nifty Pharma posted a gain of 0.53% over the previous close. That alone places the sector in positive territory and makes it one of the market areas worth tracking. Since the available verified dataset is built around current-day index pricing and constituent movement, the strongest historical comparison that can be made cleanly is today versus yesterday’s close.

Period	Value / Change
Today vs Previous Close	+143.10 points (+0.53%)
Previous Close	26,848.75
Current Close	26,991.85
Intraday Range	223.55 points

The intraday range of 223.55 points shows that the index saw meaningful movement during the session even though the final percentage gain was moderate. This tells investors that there was active participation and some push-pull between buyers and sellers before the index settled higher.

Relative strength within the sector is better captured through breadth and stock distribution than through unavailable long-period return series. On that basis, today’s session was strong enough to classify as a broadly positive sector day.

What Investors Should Watch Next in Nifty Pharma

After a positive close, the next thing investors should watch is whether the sector can build on today’s breadth. A single green day matters less if leadership narrows in the next session. But if the pack continues to show more advancers than decliners, the tone can stay constructive.

Stock-specific follow-through will also be important. Glenmark Pharmaceuticals Ltd. and Divi's Laboratories Ltd. were the standout gainers today. Investors will want to see if they sustain momentum or face profit booking. Similarly, the extent of recovery or continued weakness in JB Chemicals & Pharmaceuticals Ltd., Biocon Ltd., and Mankind Pharma Ltd. will shape the sector’s internal balance.

Another useful signal will be the behavior of heavyweight names. When stocks like Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., and Torrent Pharmaceuticals Ltd. remain stable or positive, the sector usually has a stronger base. If these names weaken while breadth also deteriorates, the index may struggle to extend gains.

Finally, traders should monitor the day high and day low from today’s session as short-term price markers. A move above the day high would show fresh strength relative to today’s range, while sustained trade below the day low would weaken the bullish reading derived from the close.

Key Takeaways

Nifty Pharma closed at 26,991.85, up 143.10 points or 0.53%.
The index opened at 26,906.55, hit a high of 27,009.95, and a low of 26,786.40.
Market breadth was positive, with 14 advancers and 6 decliners.
Advance-decline ratio stood at 2.33, showing broad participation.
Glenmark Pharmaceuticals Ltd. was the top gainer at +2.24%.
JB Chemicals & Pharmaceuticals Ltd. was the top loser at -3.87%.
Heavyweight support from names such as Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., and Sun Pharmaceutical Industries Ltd. helped the sector finish higher.
The close near the day’s high gives the session a constructive short-term price-action bias.

Featured Snippet Answers

What is Nifty Pharma?

Nifty Pharma is a sectoral index that tracks listed pharmaceutical stocks within the NSE universe. It helps investors measure how the Indian pharma sector is performing on a given trading day through the combined movement of its constituent companies.

Why did Nifty Pharma move today?

Nifty Pharma moved higher today because a majority of its constituents advanced. Fourteen out of 20 stocks closed in the green, with strong gains in Glenmark Pharmaceuticals, Divi's Laboratories, and Torrent Pharmaceuticals helping the index end 0.53% higher.

Which stock contributed the most strength today?

Based on the available constituent price action, Glenmark Pharmaceuticals and Divi's Laboratories were the strongest upside drivers in percentage terms, while Divi's Laboratories also stood out with a large absolute price gain of 179 points.

Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the worst-performing Nifty Pharma stock today. It declined 3.87%, making it the biggest loser in the index and one of the main drags on an otherwise positive sector session.

Google AI Overview Style Summary

Nifty Pharma closed higher on 28 August 2026, gaining 143.10 points or 0.53% to settle at 26,991.85. The sector’s move was supported by positive breadth, with 14 of 20 constituents advancing. The strongest gains came from Glenmark Pharmaceuticals, Divi's Laboratories, and Torrent Pharmaceuticals, while JB Chemicals & Pharmaceuticals, Biocon, and Mankind Pharma declined. The index closed near its intraday high, suggesting a constructive short-term tone based on available price and breadth data. Investors may watch whether leadership remains broad and whether the index can sustain trade near the upper end of today’s range.

Published on 28 August 2026 at 4:05 PM IST

Frequently Asked Questions

1. What is Nifty Pharma today?

Nifty Pharma today closed at 26,991.85, up 143.10 points or 0.53% from the previous close.

2. Why is Nifty Pharma rising today?

Nifty Pharma rose because 14 of its 20 constituents advanced, with strong gains in Glenmark Pharmaceuticals, Divi's Laboratories, and Torrent Pharmaceuticals.

3. What was the opening value of Nifty Pharma today?

The index opened at 26,906.55.

4. What was the high and low of Nifty Pharma today?

Nifty Pharma touched an intraday high of 27,009.95 and a low of 26,786.40.

5. Is Nifty Pharma bullish today?

On available price action, the day was bullish because the index closed higher and ended near the session high.

6. How many Nifty Pharma stocks advanced today?

Fourteen stocks advanced today.

7. How many Nifty Pharma stocks declined today?

Six stocks declined today.

8. What is the advance-decline ratio of Nifty Pharma today?

The advance-decline ratio is 2.33, showing that advancing stocks outnumbered declining stocks by more than two to one.

9. Which was the top gainer in Nifty Pharma today?

Glenmark Pharmaceuticals was the top gainer, rising 2.24%.

10. Which was the top loser in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the top loser, falling 3.87%.

11. Which heavyweight stocks supported Nifty Pharma today?

Divi's Laboratories, Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Zydus Lifesciences, Lupin, and Aurobindo Pharma all closed higher and supported the index.

12. What should investors watch next in Nifty Pharma?

Investors should watch whether the sector maintains positive breadth, whether today’s top gainers sustain momentum, and whether the index stays above the lower end of today’s trading range.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.